Bone Marrow Transplantation and Immune Deficiency

Recommend
Email
Print

Bone Marrow Transplantation and Immune Deficiency

Fig A: These magnetic resonance images show responses in two patients with recurrent sonic hedgehog–subgroup medullo-blastoma (MB) treated with vismodegib. Images were obtained at the start of therapy and at 2, 4, and 6 months after. Gold arrows indicate recurrent lesions. After initial response, MB recurs locally.

Featured Research

Vismodegib Shows Promise in Recurrent Medulloblastoma Sonic Hedgehog Subgroup

A drug that has helped some people with basal cell carcinoma also shows promise as an improved therapy for a subgroup of people with recurrent medulloblastomas.

Bone Marrow Transplant and Immune Deficiency

Click to view members

Division Summary

Research and Training Details

Faculty	15
Joint Appointment Faculty	4
Research Fellows and Post Docs	1
Research Graduate Students	1
Total Annual Grant Award Dollars	$1,284,076
Total Annual Industry Award Dollars	$257,680
Total Publications	51

Clinical Activities and Training

Staff Physicians	9
Clinical Fellows	5
Inpatient Encounters	11,502
Outpatient Encounters	7,482

Download Report in PDF Format
View Bone Marrow Transplant and Immune Deficiency

Bone Marrow Transplantation and Immune Deficiency

Bone Marrow Transplantation and Immune Deficiency

Bone Marrow Transplantation and Immune Deficiency

Featured Research

Vismodegib Shows Promise in Recurrent Medulloblastoma Sonic Hedgehog Subgroup

Division Summary

Research and Training Details

Clinical Activities and Training

About Children's

Your Children's

Find Children's